Literature DB >> 6808457

Hexamethylmelamine and hexamethylmelamine hydrochloride.

H P van de Vaart-van Zutphen, C F Smulders, J Renema, A Hulshoff.   

Abstract

Methods of analysis of the anticancer drug hexamethylmelamine, its physicochemical properties, its therapeutic uses and its fate in vivo upon oral administration, are described. The data are taken in part from the literature, in part from our own studies. The low solubility of hexamethylmelamine in water has prevented the parenteral administration of the drug to humans. The preparation of the water-soluble monohydrochloride of hexamethylmelamine, which may be suitable for this purpose, is reported, as well as its physicochemical characteristics and methods of analysis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6808457     DOI: 10.1007/BF01963657

Source DB:  PubMed          Journal:  Pharm Weekbl Sci        ISSN: 0167-6555


  17 in total

1.  Gas chromatographic determination of hexamethylmelamine in mouse plasma.

Authors:  M D'Incalci; P Morazzoni; C Pantarotto
Journal:  Anal Biochem       Date:  1979-11-01       Impact factor: 3.365

2.  In vitro studies with hexamethylmelamine.

Authors:  C J Rutty; T A Connors
Journal:  Biochem Pharmacol       Date:  1977-12-15       Impact factor: 5.858

3.  Use of ion-exchange chromatography in the spectrophotometric assay for the antineoplastic agent, hexamethylmelamine, in biological fluids.

Authors:  G T Bryan; A L Gorske
Journal:  J Chromatogr       Date:  1968-03-26

4.  Comparative pharmacology of pentamethylmelamine and hexamethylmelamine in mice.

Authors:  M Morimoto; D Green; A Rahman; A Goldin; P S Schein
Journal:  Cancer Res       Date:  1980-08       Impact factor: 12.701

5.  N-Hydroxymethylpentamethylmelamine, a major in vitro metabolite of hexamethylmelamine.

Authors:  A Gescher; M D'Incalci; R Fanelli; P Farina
Journal:  Life Sci       Date:  1980-01-14       Impact factor: 5.037

6.  Variable oral absorption of hexamethylmelamine in man.

Authors:  M D'Incalci; G Bolis; C Mangioni; L Morasca; S Garattini
Journal:  Cancer Treat Rep       Date:  1978-12

7.  Hexamethylmelamine in alkylating agent-resistant ovarian carcinoma.

Authors:  B L Johnson; R I Fisher; R A Bender; V T DeVita; B A Chabner; R C Young
Journal:  Cancer       Date:  1978-11       Impact factor: 6.860

8.  Hexamethylmelamine. An evaluation of its role in the therapy of cancer.

Authors:  S S Legha; M Slavik; S K Carter
Journal:  Cancer       Date:  1976-07       Impact factor: 6.860

9.  Analogues of hexamethylmelamine. The anti-neoplastic activity of derivatives with enhanced water solubility.

Authors:  A J Cumber; W C Ross
Journal:  Chem Biol Interact       Date:  1977-06       Impact factor: 5.192

10.  Determination of hexamethylmelamine and metabolites in plasma or serum by gas-liquid chromatography with a nitrogen-sensitive detector.

Authors:  A Hulshoff; J P Neijt; C F Smulders; A C van Loenen; H M Pinedo
Journal:  J Chromatogr       Date:  1980-03-14
View more
  1 in total

1.  The bioavailability of three altretamine formulations.

Authors:  E A Runhaar; J P Neijt; J J Holthuis; D de Vos
Journal:  Pharm Weekbl Sci       Date:  1989-12-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.